Akiko Matsuyama-Yokono Selected Research

Akiko Matsuyama-Yokono Research Topics

7	Type 2 Diabetes Mellitus (MODY) 03/2011 - 07/2008
5	Glucose Intolerance 03/2011 - 12/2008
3	Hypoglycemia (Reactive Hypoglycemia) 11/2009 - 05/2008
2	Hyperglycemia 03/2011 - 03/2009
1	Insulin Resistance 03/2011
1	Obesity 03/2011
1	Body Weight (Weight, Body) 02/2009

6	4- fluoro- 1- (((4- methyl- 1- (methylsulfonyl)piperidin- 4- yl)amino)acetyl)pyrrolidine- 2- carbonitrileIBA 11/2009 - 05/2008
5	Hypoglycemic Agents (Hypoglycemics)IBA 03/2011 - 07/2008
3	Streptozocin (Streptozotocin)FDA Link 03/2011 - 12/2008
3	Niacinamide (Nicotinamide)FDA LinkGeneric 03/2011 - 12/2008
3	Dipeptidyl-Peptidase IV InhibitorsIBA 03/2009 - 07/2008
2	Blood Glucose (Blood Sugar)IBA 11/2009 - 02/2009
2	Insulin (Novolin)FDA Link 02/2009 - 12/2008
2	Glucose (Dextrose)FDA LinkGeneric 01/2009 - 12/2008
1	Sitagliptin Phosphate (Januvia)FDA Link 03/2011
1	Rosiglitazone (Avandia)FDA Link 03/2011
1	Gliclazide (Diamicron)IBA 11/2009
1	Fatty Acids (Saturated Fatty Acids)IBA 02/2009
1	CholesterolIBA 02/2009
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 02/2009
1	LipidsIBA 02/2009
1	Triglycerides (Triacylglycerol)IBA 02/2009
1	Hemoglobin AIBA 02/2009
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2009
1	Gastrointestinal Hormones (Hormones, Gastrointestinal)IBA 01/2009
1	Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesIBA 01/2009

1	Therapeutics 03/2009
1	Glycemic Control 03/2009